The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Tardive dyskinesia and new antipsychotics
Abstract
Purpose of reviewTo provide an update on tardive dyskinesia rates in patients treated with first-generation or second-generation antipsychotics in studies published since the last systematic review in 2004.Recent findingsAcross 12 trials (n = 28 051, age 39.7 years, 59.7% male, 70.9% white, followed
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Research Diagnoses for Tardive Dyskinesia
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080014 · Cited by 937
Leucht, S., Wahlbeck, K., Hamann, J., & Kissling, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13306-5 · Cited by 725
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Self-citationAmisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Leucht, S., Pitschel-Walz, G., Engel, R. R., & Kissling, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.180 · Cited by 470
Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
Chouinard, G., & Margolese, H. C. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.013 · Cited by 416
Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial
Schooler, N., Rabinowitz, J., Davidson, M., Emsley, R., Harvey, P. D., Kopala, L., McGorry, P. D., Van Hove, I., Eerdekens, M., Swyzen, W., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.947 · Cited by 348
Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., & O'Callaghan, E. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09835.x · Cited by 332
Rosenheck, R. (2003) · JAMA · doi:10.1001/jama.290.20.2693 · Cited by 326
Risk of Tardive Dyskinesia in Older Patients: A Prospective Longitudinal Study of 266 Outpatients
Jeste, D. V. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950210050010 · Cited by 299
Morgenstern, H. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210057007 · Cited by 260
Prospective Study of Tardive Dyskinesia in the Elderly: Rates and Risk Factors
Woerner, M. G., Alvir, J. M. J., Saltz, B. L., Lieberman, J. A., & Kane, J. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1521 · Cited by 230
Prospective Study of Tardive Dyskinesia Incidence in the Elderly
Saltz, B. L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470170090030 · Cited by 183
Findling, R. L., Aman, M. G., Eerdekens, M., Derivan, A., Lyons, B., & The Risperidone Disruptive Behavior Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.677 · Cited by 161
Miller, D. D., McEvoy, J. P., Davis, S. M., Caroff, S. N., Saltz, B. L., Chakos, M. H., Swartz, M. S., Keefe, R. S. E., Rosenheck, R. A., Stroup, T. S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.034 · Cited by 158
Glazer, W. M., Morgenstern, H., & Doucette, J. T. (1993) · PubMed · Cited by 145
Croonenberghs, J., Fegert, J. M., Findling, R. L., Smedt, G. D., & Dongen, S. V. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000145805.24274.09 · Cited by 135
Jeste, D. V., Lacro, J. P., Palmer, B. W., Rockwell, E., Harris, M. J., & Caligiuri, M. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.309 · Cited by 127
Correll, C. U., & Kane, J. M. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0117 · Cited by 112
Self-citationThe treatment of tardive dyskinesia—a systematic review and meta-analysis
Soares, K., & McGrath, J. J. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00021-3 · Cited by 103
Dossenbach, M. R. K., Arango-Dávila, C. A., Ibarra, H. S., Landa, E., Aguilar, J., Caro, O., Leadbetter, J., & Assunção, S. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0810 · Cited by 93
Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia
Youssef, H. A., & Waddington, J. L. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02754.x · Cited by 88
Tenback, D. E., van Harten, P. N., Slooff, C. J., van Os, J., & SOHO Study Group (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1438 · Cited by 86
Lee, P. E., Sykora, K., Gill, S. S., Mamdani, M., Marras, C., Anderson, G., Shulman, K., Stukel, T. A., Normand, S. T., & Rochon, P. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53418.x · Cited by 85
Reyes, M., Croonenberghs, J., Augustyns, I., & Eerdekens, M. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.260 · Cited by 69
A five year follow-up study of tardive dyskinesia.
Chouinard, G., Annable, L., Mercier, P., & Ross‐Chouinard, A. (1986) · PubMed · Cited by 69
Ballesteros, J., Arrillaga, A. G.-P., & Bulbena, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00011 · Cited by 67
Tenback, D. E., van Harten, P. N., Slooff, C. J., Belger, M. A., & van Os, J. (2005) · PubMed · Cited by 62
Extrapyramidal side effects with atypical neuroleptics in bipolar disorder
Ghaemi, S. N., Hsu, D. J., Rosenquist, K. J., Pardo, T. B., & Goodwin, F. K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.10.014 · Cited by 62
Effects of Antipsychotic Treatment on Tardive Dyskinesia
Tenback, D. E., van Harten, P. N., Slooff, C. J., Belger, M. A., van Os, J., & SOHO Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0907 · Cited by 49
Gharabawi, G. M., Bossie, C. A., Zhu, Y., Mao, L., & Lasser, R. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.03.015 · Cited by 47
Eberhard, J., Lindström, E., & Levander, S. E. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000182120.51672.7d · Cited by 41
Reyes, M., Oláh, R., Csaba, K., Augustyns, I., & Eerdekens, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0504-0 · Cited by 41
Clozapine maintenance therapy in schizophrenia
Gaszner, P., & Makkos, Z. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.011 · Cited by 36
Real-Life Dosing With Second-Generation Antipsychotics
Correll, C. U. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1218 · Cited by 13
Self-citation
Cited by
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Self-citationManagement of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
The nature of relapse in schizophrenia
Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-50 · Cited by 478
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Wilson, M., Pepper, D., Currier, G., Holloman, G., & Feifel, D. (2012) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2011.9.6866 · Cited by 402
Metadata
- Authors
- Correll, C. U., & Schenk, E. M.
- Venue
- Current Opinion in Internal Medicine
- Published
- 2008-06
- Volume
- 7
- Issue
- 3
- Pages
- 295-300
- ISSN
- 1535-5942 (ISSN-L)
- OpenAlex
- W1972661776
- Cited by
- 289
- References
- 37
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.